Analysts and ONS attribute slowdown to uncertainty ahead of Reeves’ tax-raising Budget

Retailer has been hit by accounting errors that led to resignation of chief executive last month

Australian bank had cut incentives after scandals under Shayne Elliott’s watch

CEO Marc Rowan has said private equity is no longer the $900bn group’s growth driver

The Nvidia chief executive has been the driving force behind the massive AI boom which has the capacity to reshape the global economy

The surge in the precious metal’s price could have ominous implications for the markets

Fund has lower than average weighting to UK stock market

Washington shifts its campaign against Nicolás Maduro as its attacks on alleged drug smugglers come under legal scrutiny

‘International Manager’ programme closed to new recruits as CEO Georges Elhedery reshapes Europe’s largest lender

FT investigation sheds light on Wirecard fraudster’s activities in north Africa and shadow life as a Russian agent of influence

SpaceX, OpenAI and Anthropic will break new ground — potentially with the scale of their losses

Figures for September raise hopes that GDP growth in third quarter was stronger than forecast

The database company’s stock looks like a leveraged bet on OpenAI being able to meet its long-term promises

US proposes ‘compromise’ option of demilitarised buffer that excludes both Ukrainian and Russian forces, says Kyiv

An entirely subjective list of shareholder primacy, management hubris and value destruction

Leaders of Germany, France and UK hold ‘detailed’ call with Donald Trump about latest draft of peace plan

Deal forms part of broader tie-up for media group’s intellectual property to feature within ChatGPT maker’s products

There’s a lot of enthusiasm over what is increasingly seen as the next big frontier in computing

Lenders concerned they could be at significant risk of potential lawsuits from Moscow

Labour will need a different leader if it pursues a policy of rejoining the EU customs union or single market

Trial results are a boost to US pharmaceutical company’s booming obesity business

Cheaper generics will be allowed on to market a year earlier to curb costs

Beijing and several European countries hold up deal to exempt US multinationals from OECD tax regime

Neobank wants to put its £12bn of deposits to more profitable use